Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pCDNA3.3TOPO-T7-hCas9 Citations (1)

Originally described in: Mouse genome engineering via CRISPR-Cas9 for study of immune function.
Pelletier S, Gingras S, Green DR Immunity. 2015 Jan 20;42(1):18-27. doi: 10.1016/j.immuni.2015.01.004.
PubMed Journal

Articles Citing pCDNA3.3TOPO-T7-hCas9

Articles
Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa. Berthault C, Gaucher S, Gouin O, Schmitt A, Chen M, Woodley D, Titeux M, Hovnanian A, Izmiryan A. J Invest Dermatol. 2023 Dec 1:S0022-202X(23)03117-2. doi: 10.1016/j.jid.2023.10.035. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.